Services
Company
Legal and Governance
Publication Library / Publications
The use of Medtech Innovation Briefings (MIBs) to encourage implementation of innovative technologies: A review of published briefings from 2014–2018
Objectives
In an era where services are close to breaking point, there is pressure on healthcare providers to embrace cost-effective and resource-efficient innovations including medical device, digital technology, and biotech advancements. To assist UK stakeholders and encourage adoption of new solutions, the National Institute for Health and Care Excellence (NICE) recently introduced Medical Innovation Briefings (MIBs) alongside their traditional evidence-based guidance and recommendations. MIBs outline relevant information for staff, commissioners and patients, including technology descriptions, existing evidence, costs and likely resource impact in relation to standard care. This review investigates the types of technologies included in MIBs since their launch in 2014.
Methods
A systematic review of all MIBs published by NICE was conducted in May 2018. Key information, including descriptions of technologies, disease categories and care applications, was extracted and recorded within an electronic database.
Results
At data extraction (18-05-2018) a total of 143 MIBs were published, increasing from 16 published briefings in 2014 to 43 in 2017. A range of disease areas were considered including cardiovascular disease, oncology and general medicine. Common applications included disease diagnosis/detection, routine monitoring, treatment delivery, and wound management. Solutions included laboratory or point-of-care testing systems, surgical tools, non-pharmacological treatments and medical devices. One-fifth of MIBs described integrated digital health solutions. Published MIBs outlined evidence from both real world observational studies and controlled trials.
Conclusions
Although non-compulsory, the number of published MIBs is rising, suggesting an increasing focus on new innovations within the UK NHS. MIBs provide a forum for communicating the effectiveness, safety, costs and resource implications of medical technology solutions across a range of applications. Since MIBs do not include recommendations, more detailed guidance is needed to help manufacturers develop robust evidence-bases and assist stakeholders with decision-making regarding which are the most clinically-effective, resource-efficient and/or cost-effective options in comparison with standard care.
Authors
F Glen, A Pulfer
Journal
Value in health
Center of Excellence
Real-world Evidence & Data Analytics
Year
2018
Read full article